Liquidia Corp Chief Medical Officer Rajeev Saggar reported both equity award exercises and share sales. On July 10, 2026, he converted 4,487 and 3,531 performance stock units into the same number of common shares at $0.00 per unit. On July 13, 2026, he made open-market sales totaling 9,926 common shares at prices of $71.52 and $71.39 per share, executed under a Rule 10b5-1 plan adopted on December 15, 2023. A footnote states these sales were made to cover taxes from the settlement of previously granted RSUs and PSUs, while he continues to hold a significant direct equity position and additional unvested awards.
Liquidia Corp Chief Commercial Officer Scott Moomaw exercised performance stock units on July 10, 2026, receiving 7,466 shares of common stock as PSUs converted one-for-one. On July 13, 2026, he sold 9,539 shares at prices between $71.39 and $71.52 per share under a Rule 10b5-1 plan to cover taxes tied to RSU and PSU settlements. After these transactions, he holds 182,485 common shares directly, alongside various unvested RSU and PSU awards.
Liquidia Corp Chief Accounting Officer Dana Boyle exercised 3,179 performance stock units into common stock on July 10, 2026, then sold a total of 9,002 common shares on July 13, 2026 at prices of $71.52 and $71.39 per share in open-market transactions.
The PSUs convert into common stock on a one-for-one basis, and the sales were effected under a Rule 10b5-1 trading plan to cover taxes from the settlement of RSUs and PSUs granted on January 11, 2024, January 11, 2025 and July 1, 2025. Boyle continues to hold direct common stock and multiple unvested RSU and PSU awards.
Liquidia Corp director‑associated entity reports open-market sales of Common Stock. An investment entity, Canaan VIII L.P., which is associated with director Stephen M. Bloch, sold a total of 75,000 shares of Liquidia Common Stock in open-market transactions at weighted average prices around the low-$80 range.
These sales were executed indirectly through the Canaan entities, which hold the shares and whose managers collectively make investment and voting decisions. The filing states that Bloch disclaims beneficial ownership of these securities except to the extent of any pecuniary interest, and that he did not participate in the investment decision under a communications-screen policy.
BlackRock, Inc. reports beneficial ownership of 10,551,901 shares of LIQUIDIA CORP common stock, equal to 11.9% of the class as of 06/30/2026. The filing lists 10,434,552 shares of sole voting power and 10,551,901 shares of sole dispositive power. The amendment is signed 07/08/2026.
Liquidia Corp director Stephen M. Bloch reported stock transactions mainly involving an investment fund he is associated with. Canaan VIII L.P. sold 24,147 shares of Liquidia common stock at a weighted average price of $79.4474 and 853 shares at a weighted average price of $80.045.
After these sales, entities associated with Canaan VIII L.P. held 855,926 Liquidia shares indirectly, while Bloch held 71,594 shares directly. Footnotes state that Canaan Partners VIII LLC managers collectively make investment and voting decisions, and Bloch disclaims beneficial ownership of the Canaan-held shares except for any pecuniary interest and did not participate in this investment decision.
Liquidia Corp director-associated entity reports share sales. An investment fund, Canaan VIII L.P., sold a total of 100,000 shares of Liquidia common stock in open-market transactions on June 22, 2026 at weighted average prices of $75.5437 and $76.1776 per share, across ranges from $75.00 to $76.42.
The transactions are reported by director Stephen M. Bloch, but the securities are held by the Canaan entities, which collectively make investment and voting decisions. Bloch disclaims beneficial ownership except for any pecuniary interest and did not participate in this investment decision. Following these transactions, he also reports 71,594 shares held directly.
Liquidia Corp director David Johnson received a grant of 5,882 shares of common stock at no cost, reflected as a direct holding of 5,882 shares. The grant is tied to restricted stock units that convert into common stock on a one-for-one basis.
The RSUs vest upon the earlier of the one-year anniversary of the grant date or the day prior to Liquidia’s next annual shareholder meeting. Johnson is deemed to hold these securities for the benefit of Caligan-managed funds and accounts, which also indirectly hold 8,157,347 common shares.
Liquidia Corp director Raman Singh received an equity award of 5,882 shares of Common Stock as a grant with no cash paid per share. After this award, Singh directly holds 44,637 shares. The award represents restricted stock units that convert into common stock on a one-for-one basis and will vest after about a year or just before the company’s next annual shareholder meeting.
Liquidia Corp director Stephen M. Bloch reported a compensation-related equity grant. He received 5,882 shares of Common Stock at a price of $0.00 per share, recorded as a grant or award rather than an open-market purchase.
These shares arise from restricted stock units that convert into common stock on a one-for-one basis and vest upon the earlier of the one-year anniversary of the grant date or the day prior to Liquidia’s next annual shareholder meeting. Following this grant, Bloch directly holds 71,594 shares of Common Stock.
The filing also shows 980,073 shares of Common Stock held indirectly through Canaan VIII L.P. and related Canaan entities. Investment and voting decisions for these indirect holdings are made collectively by the managers of Canaan Partners VIII LLC, and Bloch disclaims beneficial ownership of those securities except to the extent of any pecuniary interest.